Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC YQA14 25mg | 1221408-42-9 | 25 MG
Supplier: Medchemexpress LLC HY11618125MG
YQA14 is a selective dopamine D3 receptor antagonist investigated as an anti-addiction agent. In animal models it inhibits morphine- and cocaine-induced conditioned place preference (CPP). Supplied as a solid research chemical for in vitro and in vivo pharmacology studies; not for human or veterinary use.
- High affinity for dopamine D3 receptor, useful for receptor pharmacology.
- Demonstrated inhibition of morphine- and cocaine-induced CPP in animals.
- Available in small pack sizes suitable for dose-ranging and animal studies.
- Supplied as a solid powder with reported high purity for research use.
- SMILES provided for cheminformatics and structural confirmation.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?